General
Australia to trial ‘backup’ COVID-19 vaccines that can be modified to fight virus mutations
Researchers behind a clinical trial of two COVID-19 vaccines in Australia say they will be able to modify the vaccinations if mutations of the virus occur.
Key points:
- Researchers say the mRNA-based vaccine and recombinant protein vaccine being trialled are more targeted
- The Doherty Institute’s Terry Nolan says it is vital Australia has its own vaccine to prevent supply chain issues
- The trials have been expedited to mid-2021 with Federal Government funding
Close to $1.6 million of Federal Government money has been awarded to the Melbourne-based trial, with hopes it will begin around the middle of this year.
Plans to roll out small amounts of the Pfizer/BioNTech vaccine in Australia in March are still in place, before domestic production of…
Continue Reading
-
General21 hours agoAlbanese government pours $12 billion into expanding AUKUS defence facility near Perth
-
General21 hours agoTrump pushes NATO nations to stop Russian oil purchases
-
Noosa News14 hours agoNoosa Reds: There’s something about tomatoes
-
Business18 hours agoWhy Macquarie expects this ASX 200 dividend stock to surge 30%